O

Oxurion NV
OXUR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€398.12K
EV
€11.27M
Shares Outstanding
4.63M
Beta
0.86

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Oxurion NV

gainify

O

Oxurion NV

OXUR

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was ...

Sector

Healthcare

Industry

Biotechnology

CEO

Ghoson, Pascal

Employees

11

IPO Date

2006-07-07

Headquarters

Gaston Geenslaan 1, Leuven, Flemish Brabant, 3001, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved